Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03197038 · ClinicalTrials.gov registry record · NA

Exercise Training and Cognitive Function in Kidney Disease

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT03197038 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03197038, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

Chronic kidney disease (CKD), affects over 45% of all individuals over 70 years of age. Patients with moderate CKD have more than a two-fold increased risk of cognitive impairment than those without CKD; furthermore, as many as 20-70% of patients with CKD have established cognitive impairment and overt dementia. The burden of cognitive impairment and dementia leads to functional decline and accelerated loss of independence, contributing to the tremendous individual, societal, and economic burden of CKD (i.e., 20% of Medicare expenditures in adults \>65 years of age). There is no recommended treatment to prevent cognitive decline in CKD patients, and the few medications available for cognitive impairment have only short term modest effects. There is a critical need to evaluate therapies to forestall cognitive impairment, and maintain or improve cognitive functioning in older patients with CKD. To address this need, this study will test the hypothesis that older patients with moderate/severe CKD and pre-clinical cognitive impairment randomized to a 6-month home-based exercise program will improve cognitive function and MRI measured brain structure, compared to a usual care control group. This study will combine an assessment of cognition with MR imaging techniques to fully evaluate brain structure, blood flow, and behavior relationships at a level previously not conducted in this population

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Partially supervised home-based walking exercise

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2017-09-01
Est. Completion 2019-12-18
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT03197038

The ClinicalTrials.gov registry entry for NCT03197038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT03197038 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03197038 about?

NCT03197038 is a clinical study titled "Exercise Training and Cognitive Function in Kidney Disease". Chronic kidney disease (CKD), affects over 45% of all individuals over 70 years of age. Patients with moderate CKD have more than a two-fold increased risk of cognitive impairment than those without CKD; furthermore, as many as 20-70% of patients with CKD have established cognitive impairment and ov...

What is the current status of trial NCT03197038?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-09-01. Estimated completion is 2019-12-18.

What interventions are being tested in trial NCT03197038?

The interventions under investigation include: Control (BEHAVIORAL), Partially supervised home-based walking exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03197038?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.